摘要 |
The present invention provides a preventive or therapeutic medicine for diabetes containing as an active ingredient a fused-heterocyclic compound of the formula (I') or its salt: [wherein G is CN, NO<SUB>2</SUB>, CO<SUB>2</SUB>R<SUP>4</SUP>, CHO, SO<SUB>2</SUB>NR<SUP>a</SUP>R<SUP>b </SUP>or CONR<SUP>a</SUP>R<SUP>b</SUP>; R<SUP>1 </SUP>is a halogen atom, a -O-R<SUP>5 </SUP>group or a -S-R<SUP>5 </SUP>group; R<SUP>2 </SUP>is a halogen atom, a -O-R<SUP>5 </SUP>group (wherein R<SUP>5 </SUP>is as defined above) or an amino group which may be substituted; and each of R<SUP>8 </SUP>and R<SUP>10 </SUP>which are independent of each other, is a hydrogen atom, a halogen atom or an alkyl group].
|